Coherus Oncology (CHRS) Interest Coverage Ratio (2013 - 2026)

Coherus Oncology has disclosed Interest Coverage Ratio across 14 years of filings, most recently posting 16.54 for Q1 2026.

• Interest Coverage Ratio for Q1 2026 came in at 16.54, up 21.74% year-over-year; the trailing twelve-month figure through Mar 2026 was 3.23 (up 80.06% YoY), and the FY2025 annual result was 4.27, up 77.03% from the prior year.
• Interest Coverage Ratio came in at 16.54 for Q1 2026 at Coherus Oncology, down from 43.04 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 43.04 in Q4 2025 to a low of 23.74 in Q4 2024.
• The 5-year median for Interest Coverage Ratio is 9.76 (2024), against an average of 9.26.
• Across the five-year window, Interest Coverage Ratio sank 431.73% in 2024 and surged 281.33% in 2025, its largest moves.
• Coherus Oncology's Interest Coverage Ratio stood at 5.49 in 2022, then slipped by 18.26% to 6.49 in 2023, then tumbled by 265.8% to 23.74 in 2024, then surged by 281.33% to 43.04 in 2025, then tumbled by 138.42% to 16.54 in 2026.
• The last three Interest Coverage Ratio figures came in at 16.54 (Q1 2026), 43.04 (Q4 2025), and 19.07 (Q3 2025), per Business Quant data.